Tablets
Tablet manufacturing is positioned as a core capability supported by organized production areas and equipment-backed operations.
Compression machines, coating systems, granulation equipment, and blending systems support the tablet profile.
Investors
A Business Profile Built for Confidence and Due Diligence
Meyonex Pharmaceuticals presents a manufacturing-focused business profile built around organized plant infrastructure, pharmaceutical formulations capability spanning solids and selected liquids and semi-solids, ISO 9001:2015–certified operations, and export-oriented logistics. This page is designed to give serious business visitors a concise overview of the company’s operating profile and manufacturing readiness.
Tarapur MIDC
Independent unit
Oral Solids
Manufacturing focus
13 countries
Referenced export profile
QA / QC
Operating structure
Company Snapshot
Company Snapshot
Meyonex is presented as a pharmaceutical manufacturing company with an independent unit at Tarapur MIDC, a formulations scope that includes tablets, capsules, dry powder sachets, liquid orals, dry syrups, and ointments, and a business profile oriented toward both domestic and international relationships.
Pharmaceutical Manufacturing Company
Meyonex is positioned around business-facing pharmaceutical manufacturing rather than consumer-health or retail product messaging.
Independent Unit at Tarapur MIDC
The operating base is an independent manufacturing unit located at Tarapur MIDC, Maharashtra, with logistical access including proximity to Jawaharlal Nehru Port Trust (Nhava-Sheva).
Formulations & Dosage Scope
The manufacturing profile spans solid oral formats and extended formulations including liquid orals, dry syrups, and ointments, alongside dry powder sachet support.
Export-Oriented Business Profile
The company profile supports both domestic business relationships and export-oriented international positioning.
Due-Diligence-Friendly Positioning
Plant capability, quality systems, documentation discipline, and production readiness form the basis of the business snapshot.
Milestone history
Recent company milestones
The eight most recent entries from the company timeline (corporate, facility, quality, export, and market-related). The complete chronological list is on About Meyonex.
Important
Entries that mention certificates, plant approval, audits, or delegations repeat wording from source materials. They are not a substitute for licence numbers, validity, scope, or current regulatory status. Confirm all credentials through primary documents and your own verification process.
- Export
Start Export House
- Export
Business delegation to Africa
- Market / audit
Plant approved — Cambodia
- Market / audit
Plant audited — Congolese Pharmaceutical Regulatory Authority (ACOREP)
- Export
Business delegation to CIS
- Market / audit
Plant audited — Ministry of Health, Yemen
- Market / audit
Plant audited — Malawi Ministry of Health
- Market / audit
Plant approved — Ghana
Manufacturing Profile
Manufacturing Profile
Meyonex’s manufacturing profile combines high-throughput solid dosage strength with a widening formulations footprint, giving business evaluators a credible view of installed capacity, equipment-backed operations, and export-oriented logistics.
Capsules
Capsule manufacturing is framed for dependable B2B manufacturing relationships within the broader formulations setup.
Capsule filling support and controlled process areas reinforce structured commercial manufacturing readiness.
Liquids, dry syrups & ointments
The company’s scope includes liquid orals, dry syrups, and ointments alongside core solid formats, reflecting evolution since establishment in 2015.
Semi-solid and liquid formulation support complements tablets, capsules, and dry powder sachet operations.
Installed Capacity Snapshot
Production Capacity Snapshot
Installed production strength helps connect Meyonex’s manufacturing story to business readiness, continuity of supply, and commercial-scale support.
Monthly installed capacity
30 Crores
Tablets / Month
10 Crores
Capsules / Month
15 Lakhs
Dry Powder Sachets / Month
Annual installed capacity (×12)
360 Crores
Tablets / Year
120 Crores
Capsules / Year
180 Lakhs
Dry Powder Sachets / Year
Facility Snapshot
Manufacturing Facility at a Glance
The facility profile is built around an independent manufacturing unit with organized floor-wise structure and distinct production, support, and utility-linked operating areas.
- Independent manufacturing unit at Tarapur MIDC with access to Jawaharlal Nehru Port Trust (Nhava-Sheva) logistics corridors
- Organized floor-wise operational structure
- Production, packing, warehouse, QC, microbiology, F&D, QA, and utility areas
- Equipment-backed environment for pharmaceutical formulations including solids, liquids, dry syrups, and ointments
- Manufacturing operations certified under ISO 9001:2015
Quality Systems Snapshot
Quality and Control Systems Overview
Quality support is framed through dedicated QA and QC structure, coverage from incoming materials through in-process and finished product stages, in-house QC infrastructure, documentation-oriented operations, and controlled design features that support more disciplined business evaluation.
- QA and QC function as organized areas within the operating structure
- ISO 9001:2015 certification for manufacturing operations
- QC coverage across incoming materials, in-process control, and finished product evaluation
- In-house QC infrastructure supports analytical and monitoring activity
- Documentation-oriented operations reinforce traceability and review
- Audit-trail-oriented data handling strengthens due-diligence confidence
- Facility and utility systems support controlled manufacturing conditions
- Validation, environmental and microbiological controls, and training and record-keeping treated as ongoing quality obligations
International Business Profile
International Market Orientation
Meyonex presents itself as an export-oriented manufacturer serving domestic and international business relationships, with current referenced markets limited to the countries shown here.
Africa
African markets explicitly referenced in export-oriented business materials.
- Burkina Faso
- Ghana
- Guinea
- Guinea-Bissau
- Kenya
- Malawi
- Niger
- Nigeria
- Rwanda
- Zambia
Asia
Asian markets explicitly referenced in export-oriented business materials.
- Cambodia
- Myanmar
Europe
European market explicitly referenced in export-oriented business materials.
- Ukraine
Read before relying on this list
The list below repeats only generic certificate, licence, and programme *titles* as they appear in historical or marketing source materials. It is not a legal register: it does not include certificate or registration numbers, validity periods, issuing file references, or jurisdictional scope. Partners and investors should treat this page as orientation only and obtain verified copies (PDFs, images, or counsel-reviewed schedules) before relying on any credential in contracts, filings, or submissions.
Meyonex can provide further particulars through formal business diligence and direct inquiry — not as a substitute for your own regulatory verification.
Accreditations & registrations
Representative titles referenced in company materials
Quality management & GMP-oriented references
- ISO 9001:2015 (Quality Management System)
- Good Manufacturing Practices
- GMP Certificate
- WHO-GMP Certificate
India: manufacturing licence forms (titles)
Common CDSCO-related labels only; no licence numbers stated here.
- Pharmaceutical Manufacturer Registration Licence
- Form 28
- Form 25
Referenced market regulators
Authority names as cited in source materials; not a claim of current approval status.
- Food and Drug Authority (GMP) — Ghana
- Pharmacy and Poisons Board — Kenya
- Zambia Medicines Regulatory Authority
Other referenced milestones & programmes
May reflect recognitions or historical milestones rather than ongoing manufacturing authorisations.
- Start Export House
- Startup India Certificate
Leadership Snapshot
Leadership and Operational Oversight
Leadership is presented here as a concise operating structure rather than a full team directory, helping serious business visitors understand the management and functional oversight behind Meyonex’s manufacturing profile.
Managing Director & Whole-Time Director
Mr. Arvind Awadhnath Sharma
Provides company-level leadership across operations and overall business direction.
Whole Time Director & CFO
Mr. Vinod Kumar Sharma
Supports the business and management structure behind Meyonex’s operating profile.
Functional oversight
Quality Control · Production · Quality Assurance · Microbiology
Why This Matters
Why Meyonex Merits Business Consideration
This page is structured as a concise business evaluation summary, connecting manufacturing, quality, facility, and market orientation in one place.
- 01
Defined Formulations & Dosage Profile
A clear scope across solids, liquids, dry syrups, and ointments makes the operating profile easier to evaluate for business review.
- 02
Commercial-Scale Capacity
Installed monthly tablet, capsule, and dry powder sachet capacity supports continuity-minded manufacturing discussions.
- 03
Organized Plant Infrastructure
A dedicated facility with structured operational areas reinforces seriousness of execution and manufacturing readiness.
- 04
Quality-Oriented Operating Systems
QA, QC, documentation, and controlled operating systems strengthen the due-diligence profile.
- 05
Export-Facing Business Profile
Domestic and international positioning gives business partners a clearer picture of Meyonex’s market-facing orientation.
Media / Business Profile Support
Operating Environment and Capability Highlights
This section is designed to support approved plant, laboratory, and production visuals later while remaining polished for business review today.
Manufacturing Facility
Reserved slot for facility overview visuals.
Quality Control Infrastructure
Reserved slot for quality control and laboratory visuals.
Production Environment
Reserved slot for controlled production area visuals.
Commercial Operations
Reserved slot for commercial-scale manufacturing visuals.
Inquiry / Document Request
Looking to Evaluate Meyonex as a Manufacturing Partner?
Meyonex combines formulations breadth, organized plant infrastructure, monthly installed production scale, ISO 9001:2015–aligned quality systems, and export-oriented logistics to support serious business evaluation for manufacturing partnerships and long-term commercial growth.
For detailed business discussions, contact our team directly.